Related Experiment Video
Updated: Oct 11, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
The tolerability of efavirenz after nevirapine-related adverse events
S Clarke1, P Harrington, M Barry
1Department of GenitoUrinary Medicine, St. James' Hospital, Dublin, Ireland. gum@stjames.ie
Abstract:
Eight patients who were infected with human immunodeficiency virus, and who had each sustained an adverse drug reaction while following a regimen including nevirapine, were switched to a regimen including efavirenz. None of the patients experienced adverse events identical to that which necessitated discontinuation of nevirapine. This study demonstrates that adverse events related to nevirapine are not a class-specific effect.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Antiviral Nucleoside Inhibitors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Risk factors
Inhibitors of Viral Protein Synthesis

